Impact of HIV-1 capsid polymorphisms on viral infectivity and susceptibility to lenacapavir
ABSTRACT Lenacapavir (LEN) is a first-in-class capsid (CA) inhibitor for the treatment and prevention of HIV-1 infection. While LEN has shown potent antiviral activity across all major HIV-1 subtypes, the impact of existing HIV-1 CA sequence diversity on the activity of LEN remains to be determined....
Sparad:
| Huvudupphov: | , , , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
American Society for Microbiology
2025-05-01
|
| Serie: | mBio |
| Ämnen: | |
| Länkar: | https://journals.asm.org/doi/10.1128/mbio.00187-25 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|